That's essential, due to the fact that the method a protein in the body folds figures out if a pharmaceutical will have the ability to bind to that protein and be efficient. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (jeff brown biotech genome sequencing). Today, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was a breakthrough nearly nobody saw. But it's going to have profound implications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be lots of investment opportunities in this area, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (self-driving cars). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back maybe substantially prior to going higher - what is the legacy report predicting. I've been covering bitcoin for a long time now. One of the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly informing readers. But that's not the big concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown predictions 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of terrific personal companies on the brink of striking the public markets And I've been dealing with a new way for you to invest even prior to these business go public.
This opportunity has been constructing over the last couple of years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to schedule your spot totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers know that tech isn't our typical beat (last week). And when it pertains to tech investing, we leave it to the professionals. The good news is, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we know (longtime readers). In fact, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the big image and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing exponential growth and creating extraordinary chances for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. brownstone research. However in spite of what lots of readers might believe, this is a trend that's simply getting going. Even though the COVID-19 pandemic interfered with supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this eventually led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown 2021 stock picks). Losing 2 months of manufacturing and sales really impacts the number of 5G gadgets are sold in the fiscal year. When you consider all of that, offering 250 million units is remarkable. More importantly, the delays triggered by the pandemic developed a ton of bottled-up need. Which need is now going to be pressed into 2021. In fact, I forecast that more than 500 million 5G devices will be delivered in 2021 - first lady. Which's not my only 5G prediction When I have actually talked about 5G in the past, I have actually described its 3 various phases.
In Stage Two, 5G gadgets go on sale. 5G phones and other items start to reach consumers. And in Phase 3, 5G services start to be provided (future report review). That's when we start to see applications working on 5G networks. Think about things like huge multiplayer video games over a mobile phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage 3 by this summertime. This starts something of a virtuous cycle: The majority of people don't really care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In reality, 5G is going to open a suite of unbelievable applications: self-driving cars and trucks, the Web of Things, robotic surgical treatment, and more. All of these innovations need 5G. The investment chances going forward will be huge. Stepping away from 5G, the next important technology I predict in 2021 is CRISPR genetic editing. CRISPR stands for "clustered regularly interspaced short palindromic repeat." It's a mouthful. However it is among the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not function properly. CRISPR uses a similar idea however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For many years, CRISPR was mainly a specific niche innovation that wasn't well understood. And during that time, there were truly just 3 business operating in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with diseases and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR companies is going public and providing extraordinary returns. This whole market is effectively a greenfield opportunity.
There's room for lots of business to exist in this area. jeff brown tech stock 2021. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or 3 more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its latest Alpha, Fold software can precisely predict the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That's important since the way a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error procedure. Today, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're developed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but a number of drug treatments produced using this technology. This was one of those breakthroughs that almost no one discovered. However it's going to have profound ramifications for treating disease. And, naturally, there will be lots of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back perhaps substantially prior to going greater. I have actually been covering bitcoin for a long time now. Among the first research reports I ever released was on bitcoin - biotech stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that preliminary suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But nobody is asking that concern any longer. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche business. future report review. Mass, Mutual is a 150-year-old organization. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information is up to date as of February 2021, however we could not independently validate this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to pick winning technology stocks. He spent more than 25 years researching innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an outstanding point of view on the market. He's constantly on the hunt for new opportunities, and he shares a lot of his finest choices in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully predicted some of the biggest economic events of the previous 20 years. Although he doesn't appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it best every time, however Jeff Brown's accurate forecasts have actually made him legions of devoted fans. That states a lot about his ability. The Near Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research study offers a number of research services with a wide range of expertises - genetic sequencer stock jeff brown.
The company is likewise affiliated with Bonner & Partners, another well-respected research publisher - tech stock. On its website, Brownstone states its objective is to provide retail financiers with professional-grade research: "For too long, the very best financial investment research has not been readily available to private financiers. It has actually been usually reserved for investment banks, hedge funds, private equity, and high-net-worth customers. jeff brown biotech stock pick for 2020. The mission of Brownstone Research study is to make that type of proprietary research readily available to any financiers wanting to acquire an edge in the markets. The objective is basic to deliver distinct and lucrative investment research study found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise acts as the company's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After years of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout many of America. If you know even a bit about the market, you know that he has a track record as a King Midas of sorts. melania trump. Whatever he touches turns to gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge project.
In truth, Brown thinks S.A.V. diplomatic relations. could be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding 2 cutting-edge innovations: synthetic intelligence and electrical cars and trucks. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing except the automobile industry's Holy Grail. As you know, electric lorries and self-driving automobile stocks have been substantial this year, however the Wall Street device has actually approved hype without much concrete outcome. Regardless of an extreme increase in competitors over the past few years, Brown still thinks Musk has the very best opportunity of putting all of it together.
tech might be the magic string that connects it all together. S.A.V. stands for Shared Autonomous Vehicle, and it could be the future of transport. Basically, this innovation would enable you to lease your cars and truck as an autonomous, self-driving taxi when you're not using it. You simply leave the cars and truck and press a button on an app that tells the vehicle to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a significant piece of the revenues. It sounds crazy, however it might be closed than you think.